- recruitingTherapeutic confirmatory (Phase III)
A phase III study to assess efficacy and safety of N-Acetyl-GED-0507-34-LEVO gel 5%, applied once daily for 12 weeks in patients with acne vulgaris (GEDACNE-2)
This study tests a new gel called N-Acetyl-GED-0507-34-LEVO for acne. Researchers want to see if applying the gel once a day for 12 weeks helps clear spots on the face and body better than a dummy gel. It aims to find safe, effective new treatments for acne vulgaris.
Italy · Spain · Poland - recruitingTherapeutic exploratory (Phase II)
A phase 2 randomized, double blind, placebo-controlled study to evaluate the safety and efficacy of topical AT-004 1% in the participants with acne vulgaris.
This clinical trial is testing a new skin cream called AT-004 for adults with acne. Researchers want to see if applying this cream helps reduce spots and redness compared to an inactive dummy cream (placebo). The study also checks how gentle and safe the treatment is for the skin.
Denmark - recruitingTherapeutic confirmatory (Phase III)
A phase III study to assess efficacy and safety of N-Acetyl-GED-0507-34-LEVO gel 5%, applied once daily for 12 weeks in patients with acne vulgaris (GEDACNE-1)
This study is testing a new gel for acne called N-Acetyl-GED-0507-34-Levo. It wants to see how well it works and if it's safe when used once a day for 12 weeks. Researchers will check if it reduces spots and how clear skin becomes.
Spain · Italy · Poland - recruitingTherapeutic confirmatory (Phase III)
A multicenter, randomized, double-blind, parallel, three-arm, active- and placebo-controlled therapeutic equivalence study for the comparison of clindamycin + tretinoin/Verisfield gel (1+0.025)% with Acnatac®/Meda gel [clindamycin + tretinoin (1+0.025)%] in the treatment of acne vulgaris.
This study compares a new gel for acne, made by Verisfield, with an existing one called Acnatac®. Both gels contain the same active ingredients. Researchers want to see if the new gel works just as well and is safe for treating acne.
Greece - completed
Acne care online
Acne is a common skin condition that can affect your confidence. This UK study is testing a new website designed to help young people aged 13 to 25 manage their acne. Researchers want to see if reliable online advice improves skin health and reduces the need for long-term antibiotics.
United Kingdom · England - recruitingPHASE3
Clinical Trial to Compare Oral Isotretinoin to Standard of Care in Moderate Acne Skin of Color Patients
This study is looking at how well a medication called isotretinoin, taken by mouth, works for moderate acne in people with darker skin tones, compared to usual treatments. It wants to see if this medication can help reduce dark spots left after acne.
France · French Guiana